Skip to main content
Clinical Trials/JPRN-UMIN000051539
JPRN-UMIN000051539
Completed
未知

Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy versus R0 Resection for Resectable Colorectal Cancer with Peritoneal Metastases with Low Peritoneal Cancer Index Score: A Collaborative Observational Study from Korea and Japan - CRS + HIPEC vs R0 resection alone

Yonsei University College of Medicine0 sites166 target enrollmentJuly 6, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Colorectal Cancer with Peritoneal Metastases
Sponsor
Yonsei University College of Medicine
Enrollment
166
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 6, 2023
End Date
March 31, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Patients with appendiceal cancer were excluded.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 2
Role of surgery and heated intra-abdominal chemotherapy in patients with large bowel cancer that has spread to the abdominal lining membraneHealth Condition 1: null- Colorectal Adenocarcinoma
CTRI/2017/08/009498Investigator initiated trial15
Active, not recruiting
Phase 1
Randomized study comparing surgery and local chemotherapy versus standard chemotherapy in the treatment of colorectal carcinomatosis.Resectable colorectal carcinomatosis.MedDRA version: 14.1Level: LLTClassification code 10050035Term: Metastatic colon cancerSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]
EUCTR2012-004058-27-ITISTITUTO ONCOLOGICO VENETO122
Recruiting
Phase 2
Role of surgery and heated chemotherapy in the abdominal cavity for patients with recurrent ovarian cancerHealth Condition 1: null- Recurrent ovarian cancer
CTRI/2017/09/009607Investigator initiated trial15
Active, not recruiting
Phase 1
Assessment of cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in first or secondary platinum-resistant recurrent ovarian epithelial cancer.HIPOVA-01Patients with First or second recurrence of platin-resistant epithelial ovarian cancerMedDRA version: 20.0Level: PTClassification code 10033128Term: Ovarian cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]
EUCTR2019-002480-94-FRHospices Civils de Lyon220
Completed
Not Applicable
Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal metastasis from colorectal or appendiceal cancer: a feasibility studyPeritoneal metastasis from colorectal or appendiceal cancer
JPRN-UMIN000021325ational Center for Global Health and Medicine10